Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2006, p. 1561-1563, Vol. 44, No. 4
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.4.1561-1563.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Virology,1 Infectious Diseases,2 Internal Medicine Departments, Pitié-Salpêtrière Hospital, Paris, France3
Received 8 September 2005/ Returned for modification 29 October 2005/ Accepted 26 January 2006
The performance of a new combined antigen-antibody assay (Monolisa HCV Ag-Ab Ultra; Bio-Rad Laboratories) was evaluated in the context of acute hepatitis C in human immunodeficiency virus-infected patients. The combined assay became positive as early as the first PCR and earlier than a third-generation enzyme-linked immunosorbent assay in 65% of the cases. Reduction of the long period of HCV seronegativity should improve the diagnosis of hepatitis C infection, especially in high-risk populations.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»